Table 1 The demographic results, aetiology of the keloid, causes of the medical seeking, and the duration of keloid existence (group A, patients with therapy; group B, without treatment (control group); SD, standard deviation)
From: Impact of intralesional botulinum toxin type A therapy on the keloid-related quality of life
Total n = 140 | Group A n = 83 | Group B n = 57 | p-value | ||
|---|---|---|---|---|---|
Age (years) (mean ± SD) | 35.61 ± 10.83 | 36.82 ± 10.6 | 33.86 ± 11.01 | 0.113 | |
Sex | Male | 69/140 (49%) | 45/83 (54%) | 24/57 (42%) | 0.108 |
Female | 71/140 (51%) | 38/83 (46%) | 33/57 (58%) | ||
Aetiology | Surgical | 60/140 (42.9%) | 39/83 (47%) | 21/57 (36.8%) | 0.732 |
Piercing | 7/140 (5%) | 3/83 (3.6%) | 4/57 (7%) | ||
Burn | 19/140 (13.6%) | 10/83 (12%) | 9/57 (15.8%) | ||
Cut | 33/140 (23.6%) | 19/83 (23%) | 14/57 (24.6%) | ||
Acne | 21/140 (15%) | 12/83 (14.5%) | 9/57 (15.8%) | ||
Motivation for medical management | Pain | 18 (12.9%) | 13/83 (15.7%) | 5/57 (8.8%) | 0.529 |
Growth | 16 (11.4%) | 9/83 (10.8%) | 7/57 (12.3%) | ||
Change of appearance | 12 (8.6%) | 7/83 (8.4%) | 5/57 (8.8%) | ||
Family urging | 16 (11.4%) | 6/83 (7.2%) | 10/57 (17.5%) | ||
Problems with social life | 36 (25.7%) | 21/83 (25.3%) | 15/57 (26.3%) | ||
Problem with work | 38 (27.1%) | 24/83 (28.9%) | 14/57 (24.6%) | ||
Others | 4 (2.9%) | 3/83 (3.6%) | 1/57 (1.8%) | ||
Duration of keloid existence (years) (mean ± SD) | 3.91 ± 1.76 | 3.71 ± 1.82 | 4.19 ± 1.79 | 0.08 | |